In depth studies had found that DLGAP5 was an essential and conserved cell cycle regulating gene, whose expression level was affected by the degree of promoter methylation, controlled by hypoxia-control, and could enhance the resistance of tumor cells to chemotherapy and radiotherapy. The gene discussed is DLGAP5; the disease is neoplasm.